Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Management of Cancer Genomic Board and Preparation of Genomic Report].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Aug 2020

Nakamura Kohei, Nishihara Hiroshi

Abstract excerpt

The accumulation of gene alteration is the major pathogenicity of any types of cancer. The concept of precision cancer medicine is therefore the individualized treatment based on the driver gene alteration in each case. The cancer gene profiling (CGP) test, so called gene panel test, will be the major clinical examination to identify the driver gene alteration usually using the FFPE tissue from the surgically...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to Japan
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 32829344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Management of Cancer Genomic Board and Preparation of Genomic Report].PMID 32829344Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

Clinical Utility of Comprehensive Genomic Profiling Tests Using MTB Management System at a Single Center in JapanSemantic proximity Read ↗

Cancer genomic medicine in JapanSemantic proximity Read ↗

The molecular tumor board—a key element of precision oncologySemantic proximity Read ↗

A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study).Semantic proximity Read ↗

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer.Semantic proximity Read ↗

Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.Semantic proximity Read ↗

Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II Study Protocol KCSG AL-22-09Semantic proximity Read ↗

Clinical Benefit and Agenda for Clinical Sequencing Using Cancer Panel Testing: A Retrospective Clinical StudySemantic proximity Read ↗

Next generation sequencing‐based gene panel tests for the management of solid tumorsSemantic proximity Read ↗

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.Semantic proximity Read ↗

The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.